Maximizing tumor microenvironment analysis for TILs from limited patient samples

A complex interaction among heterogenous immune and tumor cells within the tumorous tissue not only influences tumor progression, but can also shape therapeutic responses. Understanding such interactions and cellular phenotypes within the tumor microenvironment is key to developing future immune-based cancer therapy strategies. Limited patient sample material, and loss of said precious material along the workflow, are major challenges in performing elaborate or detailed study of such complex microenvironments.

 

Learning Objectives